Free Essay

Glaxosmithkline

In: Business and Management

Submitted By slcmom911
Words 735
Pages 3
An analysis of GlaxoSmithKline and AIDS Drugs in South Africa

Maker of AIDS drugs, GlaxoSmithKline (GSK), is confronted with a question of ethics. Do they go the humanitarian route and provide drugs for AIDS victims in poor countries, or do they maintain that they’re a business and they’re here to make money? South Africa has the highest population of AIDS patients in the world. In the year 2000 roughly five million people (or 20%) of the population were infected with the disease. At this time some drugs to attack the virus had been developed. The problem was the cost of this treatment method (HAART) cost an estimated $10,000 to $15,000 a year. The average annual income in South Africa was approximately $2,000. What is a nation to do when a disease is spreading rapidly, killing off your people? The South African government decided to take matters into their own hands. If companies such as GSK wouldn’t make AIDS drugs affordable for their people they would get the drugs another way. In 1997 Nelson Mandela introduced the Medicines and Related Substances Control Amendment. With this amendment the South African government could import generic drugs. They saw this as the only way to get affordable AIDS drugs to help infected victims of the disease. In 1998 GSK and 41 other pharmaceutical companies filed a lawsuit against the South African government, brought on by the South African Medicines and Related Substances Control Amendment. The lawsuit argued that the amendment would allow the health minister to arbitrarily ignore patents on medications. And they were right. But is it a battle worth fighting? The merger that would become GlaxoSmithKline resulted in the largest pharmaceutical company in the world. They were also the largest AIDS drug producer in the world. AIDS drugs alone generated $2 billion in sales in 2000. South Africa represented only 1% of global sales for the company. GSK was a huge, profitable company, but with a pending lawsuit involving a question of ethics it made them a target for attacks from all angles. Many non-governmental organizations launched attacks and campaigns against GSK, demanding they remove the lawsuit against the South African government. Sixteen members from Globalise Resistance protested outside of GSK’s plant in Brentford, London. Oxfam International launched their “Cut the Cost” campaign to protest all pharmaceutical companies charging excessive prices in developing countries. Because it appeared that GSK was willing to sacrifice lives to make money NGO’s such as these and several others took a stand against the pharmaceutical powerhouse.
So was the 1% market worth the black eye it was given for claiming what they were entitled to? I don’t think so. While GSK had every right to be upset with the amendment introduced in 1997 which infringed upon their patents fighting it only proved to hinder more than help. It is my opinion that they would have been wise to recognize that a country such as South Africa won’t be able to pay the premium price for the drugs they so desperately need. By discounting them substantially or donating them all together they would be looked upon differently by the world, not as a pharmaceutical superpower that cares about nothing but the bottom line, but as a company that is genuinely concerned about the welfare of the world. Don’t get me wrong, I’m all for capitalism, but in a situation such as this one could do a lot of good for a company by giving a little and getting a lot back in return. I believe to be successful long term you have to look to the future, not just the “now.” The positive publicity and positive results from this type of action are immeasurable. The business generated could be tenfold the business they would have received selling drugs at a premium to South Africa.
In the end GSK ended up doing just that, they discounted their AIDS drugs to make them affordable to the people of South Africa and other underdeveloped nations. It could have been from the pressure of the NGO’s. It could be they felt they had more to gain in the long run by doing so. One thing is for certain, the damage had been done to GSK’s image. Had they not filed the lawsuit against the South African government, had they discounted the drugs initially, GlaxoSmithKline could have emerged as the humanitarian pharmaceutical superpower.

Similar Documents

Premium Essay

Product Comparisons of Nestle Glaxosmithkline and Cadbury

...already complete and they do not have to add anything. Add more ingredients To differentiate Milo from other product they have produce a healthy Milo by adding cereal in Milo Fuze. This Milo is very suitable for consumer that concern about healthy and on diet because cereal can avoid people from feeling hungry and contain fiber that good for digestion. Milo also contains a lot of nutrition which does notcontained in the other competitor’s product such as Oligo Coco. Oligo Coco is just a normal chocolate malt drink and they do not have nutrition such as Milo. (http://www.scribd.com/doc/26214574/15/Information-in-Milo-Packaging) HORLICKS BRANDING: Horlicks is the name of a company and of a malted milk hot drink. It is manufactured by GlaxoSmithKline and it is available in the United Kingdom, South Africa, New Zealand, Bangladesh, India, Pakistan and Jamaica, and under licence in the Philippines and Malaysia. Horlicks has been the most leading brand leading and the most famous healthy food drink brand across the world and as well as in Bangladesh. ORIGIN: Product Origin: product of England (check this not sure). PACKING: This gave GSK the thought of unifying the logo, packaging and designing across all the product categories of Horlicks. The new look and design have evolved from consumer research across the segments along with attributes of the brand. The elements in the new design are: - * The ‘Wave’ on the packaging shows the ‘activity’ of a person * The......

Words: 1407 - Pages: 6

Premium Essay

Glaxosmithkline Found Guilty in Criminal Case

...Summary GlaxoSmithKline (GSK) is one of the main pharmaceutical and healthcare drug developer and manufacturer in the world. The product liability case with the British company, GSK includes the drugs Avandia, Paxil, Wellbutrin, and others (Thomas & Schmidt, 2012). The drug maker pleaded guilty and agreed to pay fines from the criminal charges in the case. GSK promoted its antidepressants for unapproved uses and failing to report safety data to the FDA on their diabetes drug. In addition, there are civil penalties within this case for improper marketing on six other drugs. The fines are the largest settlement within the pharmaceutical industry, totaling 3 billion (Thomas et al., 2012). There have not been any charges placed against personnel of GSK, at this time. However, GSK has agreed to withdraw bonuses from executives in their part of this illegal behavior. The claims in this case are improper practices during the 1990 to the mid 2000’s, came from former employees of GSK, which include the regional vice president and senior marketing manager (Thomas et al., 2012). The criminal and civil claims include the following: • Even though it was known the drug was linked to suicidal thoughts in teens, GSK promoted the use of Paxil to children. GSK misrepresented information on a clinical trial in a medical journal on the drug. • Wellbutrin was approved for depressive disorder; however, was promoted to use for off-label promotions of various products, “weight loss......

Words: 1317 - Pages: 6

Free Essay

Glaxosmithkline, Epizyme and Constellation Pharm.

...CHEM 5 Quantitative Analysis Laboratory Outline. 55labout.doc 02/06/05 Objectives: • development of quantitative laboratory skills • introduction to modern analytical science • Approach: • solve a series of chemical analysis problems with various techniques and instruments • certify laboratory instruments and standards • maintain laboratory records in compliance with Good Laboratory Practice Guidelines Schedule: Weeks 1-6 - Perform a Basic Set of 8 fundamental experiments (Series A) Weeks 5-15 Two parallel activities will be sustained: - Perform a series of quantitative studies (Series B) - Calibration of laboratory instruments (Each student or student group will perform each experiment in the B-series.) (Each student or student group will perform the calibration of laboratory instruments __________________________________________________________________ Series A. Basic Quantitative Techniques Introductory Experiments (A-1) Experiment 1 Use of the Analytical Balance (page 727) (A-2) Experiment 2 Use of the Pipet and Buret and Statistical Analysis (page 729) Gravimetric Analysis (A-3) Experiment 3 Gravimetric Determination of Chloride (page 730) Volumetric Analysis Acid-Base Titrations Neutralization Titrations (A-4) Experiment 6 Determination of Replaceable Hydrogen in Acid by Titration with Sodium Hydroxide (page......

Words: 606 - Pages: 3

Premium Essay

Glaxosmithkline Pestel Analysis

...GlaxoSmithKline PESTEL Analysis. The level of implementation of GlaxoSmithKline (GSK) marketing strategy is subject to a range of external and internal factors that shape overall marketing environment for the business. PESTEL strategic analytical tool can be used to study the impacts of external factors to the business where the abbreviation stands for political, economical, social, technological, ecological, and legal factors. Political factors affecting the implementation of GSK marketing strategy include possible changes in international trade regulation and competitive regulation likely to be introduced by the governments of China and India. Economic factors impacting GSK marketing strategy include high rate of economic growth in China and India. Moreover, current economic uncertainties associated with European markets might have negative implications on the marketing strategy Social factors with potential implications on GSK marketing strategy are changes in consumer lifestyles, shifts in consumer attitudes and opinions etc. However, Cameron (2012) specifies increasing level of customer resentment towards large amounts of profits made by pharmaceutical companies and sliding images of large pharmaceutical companies as the most significant social factor in the current environment. Technological factors include breakthroughs in pharmaceutical industry, issues associated with licensing and patenting drug manufacturing technology, as well as, the level of......

Words: 273 - Pages: 2

Premium Essay

Legal and Ethical Issues

...Legal and Ethical Issues (GlaxoSmithKline in $3 billion fraud settlement) In cases like the GlaxoSmithKline fraud settlement there are legal and ethical issues affected. Ethically it was wrong for GlaxoSmithKline to put profit before the health of the public. Ethical issues do not have to be proven in court. Most individuals know and understand ethics as a basic human guideline for behavior. With thing legal issues it is a bit more difficult. In order to take action toward GlaxoSmithKline legally the allegations need proving. There was an allegation of GlaxoSmithKline using drugs for purposes which they had not been approved. GlaxoSmithKline also failed to report safety data about top drugs. Ethical and legal issues often times overlap, however in some cases not. It is our job as consumers to hold those who jeopardize patients’ health, harm taxpayers, and violate the public trust accountable for their actions. (Deception Duke) The video displayed many legal and ethical issues. The ethical issues against Duke were insurmountable. There were several opportunities to stop the study. Information was brought to their attention that raised suspicion, but they chose to ignore them. It was stated that they did not know about the fraud. I believe this to be true, but most importantly I don’t think they wanted to know. Even after the introduction of several red flags Duke chose to ignore them. Duke may not have any legal obligations to put a regulatory system in place to......

Words: 824 - Pages: 4

Free Essay

Business Research Ethics

...Business Research Ethics By: xx Class: RES/351 Due Date: 16 December 2013 Instructor: xx In July 2012, GlaxoSmithKline agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs. GlaxoSmithKline committed unethical behavior by neglecting to turn in all research on their pharmaceuticals. By them not turning in all the research it hid some information that was critical to rather or not the drug was legal and healthy for the prescribed patients. GlaxoSmithKline failed to report certain safety data that could have caused major harm to anybody that used their product. Blinded by the greed and wanting to produce a well profitable product, GlaxoSmithKline withheld the information and released their drugs. With the safety data withheld and the health care representatives still passing out drud samples to hospitals and clinics throughout the United States, this could have caused a significant medical problem. The possibility of the drug medically injuring a patient would be the worst situation imaginable. The patient is not the only one that could have been injured due to the lack of research GlaxoSmithKline announced about the product. The doctors and clinics who the patients received the drugs from would also be hurt. Granted the doctors and clinics would not be hurt physically, their reputation and image could be significantly damaged if they were the ones who......

Words: 786 - Pages: 4

Premium Essay

Pestel

...16/9/2014 Pest Analysis On GlaxoSmithKline (GSK) Home Sign Up Forums Projects Institutes Articles Blogs Videos Communities Events Jobs Login Search Forums.. Remember Me? Log in ManagementParadise.com Forums - Your MBA Online Degree Program and Management Students Forum for MBA,BMS, MMS, BMM, BBA, students & aspirants. > Projects HUB for Management Students ( MBA Projects and dissertations / BMS Projects / BBA Projects > PUBLISH / UPLOAD PROJECT OR DOWNLOAD REFERENCE PROJECT > Principles of Management ( P.O.M) Login via Facebook? User Name User Name Password Pest Analysis On GlaxoSmithKline (GSK) Pest Analysis On GlaxoSmithKline (GSK) Pest Analysis On GlaxoSmithKline (GSK) You are currently logged in to Facebook. Would you like to autologin to the network? Autologin or Cancel » Login Discuss Pest Analysis On GlaxoSmithKline (GSK) within the Principles of Management ( P.O.M) forums, part of the PUBLISH / UPLOAD PROJECT OR DOWNLOAD REFERENCE PROJECT category; GlaxoSmithKline plc often abbreviated to GSK, is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United ... Forgot Password? New User? LinkBack Thread Tools Display Modes Log in Sign Up A dv ertisements Pest Analysis On GlaxoSmithKline (GSK) (1 (permalink)) » Ads Abhijeet S Pest Analysis On GlaxoSmithKline (GSK) - December 2nd, 2010 GlaxoSmithKline plc often......

Words: 1382 - Pages: 6

Free Essay

Glaxosmithkline Case Analysis

...Definition of the Problem Consumers are taking advantage of price differentials for prescription drugs in other global markets by either physically crossing over to the Canadian border or ordering them from the internet. Analysis In an increasingly global environment, companies must become more aware of an empowered consumer. Information, such as pricing in other countries, is able to spread very quickly. American consumers often wish to be on an equal playing field with the rest of the world. This means that a service/good that is bought in the United State should be comparable in price/quality to the same good/service bought in another country. GSKoSmithKline (GSK) encountered numerous public relations and strategic issues with their decision to limit the supply of drugs shipped to Canada. Many American consumers chose to buy the cheaper versions of the drugs from Canadian pharmacies because of the significant price reduction. Many of these consumers, who were often low income or elderly, could not afford the United States drugs because of the expense. GSK’s Responsibility to American Patients Healthcare is a business, but it must be treated differently than other businesses. GSK has both a social and ethical commitment to produce life-saving drugs that are affordable and easily accessible to the American public. The large price differentials between drugs purchased in America and drugs purchased in Canada led many to believe that GSK was a profit-hungry......

Words: 1243 - Pages: 5

Premium Essay

Performance Appraisal Process of Glaxosmithkline (Gsk) Bangladesh Limited

...Administration Jatiya Kabi Kazi Nazrul Islam University BBA Program “Human Resource Management” Topic Performance Appraisal Process of GlaxoSmithKline (GSK) Bangladesh Limited. Course coordinator Amita Das Lecturer, Dept.of HRM Date of Submission - 08/07/2012 Submitted by Md.Shamirul Islam 2nd year 1st semester ID: 11133027 Letter of Transmittal July 08, 2012 Amita Das Lecturer, Dept of HRM Jatiya Kabi Kazi Nazrul Islam University Subject: Submission of Assignment on Performance Appraisal Process of GSK Limited Bangladesh. Dear Madam, I feel very glad to inform you that I am going to submit my assignment titled HRM based on Performance Appraisal Process of GSK Limited Bangladesh. I have tried my level best to prepare this assignment & included all those data that is essential for it. Thanking you for your valuable information. Sincerely yours, ............................... Md.Shamirul Islam   Executive summary As a part of our curriculum we have to prepare reports in each semester for each subject. In this way, my course teacher has assigned me to prepare the report. And the topic of my report is “Performance Appraisal Process of GlaxoSmithKline (GSK) Bangladesh Limited”. She took a lecture on preparation of this report and serving us necessary documents. As I have selected a pharmaceutical organization, my prime......

Words: 4236 - Pages: 17

Premium Essay

Management Control Systems of Glaxosmithkline

...competitive advantage. Management controls are only one of the tools which managers use in implementing desired strategies. However strategies get implemented through management controls, organizational structure, human resources management and culture. In this paper we will discuss how management control system is implemented in various sectors of an pharmaceutical company ie. “GlaxoSmithKline Bangladesh Limited”. GlaxoSmithKline Bangladesh Limited carries with it an enviable image and reputation for the past 6 decades. A subsidiary of GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical and healthcare companies GSK Bangladesh, continues to be committed to improving the quality of human life by enabling people to do more, feel better and live longer. The Company’s principle activities include secondary manufacture of pharmaceutical products and marketing of vaccines, pharmaceutical and healthcare products. GlaxoSmithKline Bangladesh Limited implements many control systems to attain their strategic objectives and competitive advantages. Some models that GlaxoSmithKline uses to make their activities and resources effective & efficient, for their employee performance evaluation and to enhance the overall performance of the organization will be discussed in this paper. Management Control Systems 1.1 Introduction: A management control systems (MCS) is a system which gathers and uses information to evaluate the performance......

Words: 4708 - Pages: 19

Free Essay

Glaxosmithkline Case Analysis

...In: Business and Management Glaxosmithkline Case Analysis Definition of the Problem Consumers are taking advantage of price differentials for prescription drugs in other global markets by either physically crossing over to the Canadian border or ordering them from the internet. Analysis In an increasingly global environment, companies must become more aware of an empowered consumer. Information, such as pricing in other countries, is able to spread very quickly. American consumers often wish to be on an equal playing field with the rest of the world. This means that a service/good that is bought in the United State should be comparable in price/quality to the same good/service bought in another country. GSKoSmithKline (GSK) encountered numerous public relations and strategic issues with their decision to limit the supply of drugs shipped to Canada. Many American consumers chose to buy the cheaper versions of the drugs from Canadian pharmacies because of the significant price reduction. Many of these consumers, who were often low income or elderly, could not afford the United States drugs because of the expense. GSK’s Responsibility to American Patients Healthcare is a business, but it must be treated differently than other businesses. GSK has both a social and ethical commitment to produce life-saving drugs that are affordable and easily accessible to the American public. The large price differentials between drugs purchased in America and drugs purchased......

Words: 330 - Pages: 2

Premium Essay

Case Study

...Case Study: GlaxoSmithKline, Bristol-Myers Squibb, and AIDS in Africa In this case study analysis paper, I shall argue that it is morally acceptable for Indian drug companies to copy and sell the AIDS drugs developed by GlaxoSmithKline and Bristol-Myers Squibb. The reasons and evidence that support this moral judgment are as follows: Utilitarianism states that an action is morally correct if the sum total benefits produced by the action is greater than the sum total of benefits produced by any other action that could have been performed in its place. In other words, does the action maximize benefits and minimize injuries to those affected by it? In this case study it’s known that AIDS is a major global problem, and by the Indian drug companies selling the drug developed by GlaxoSmithKline and Bristol-Myers Squibb would help the 28 million people infected with the disease in sub-Saharan Africa where the epidemic is at its worst and most of the individuals affected by it cannot afford the GlaxoSmithKline and Bristol-Myers Squibb made drugs. Since GlaxoSmithKline and Bristol-Myers Squibb will not provide a reasonably priced drug cocktail and the Indian drug companies will, the Indian drug companies will be able to save tens of thousands to hundreds of thousands (possibly even millions) of lives. Preserving life is the ultimate benefit that any action can produce. By preserving life many benefits subsequently follow. The individuals who will now live longer due to the......

Words: 2991 - Pages: 12

Premium Essay

Impact of Brand Identity of Horlicks in Consumers' Purchase Intention

...Course Title: Thesis Paper A Research Paper on “How brand elements influence the consumers’ purchase intention of a brand: A study on Horlicks and GlaxoSmithKline” Prof. Dr. Md. Masudur Rahman Professor Department of Marketing University of Dhaka Prof. Dr. Md. Masudur Rahman Professor Department of Marketing University of Dhaka Prepared For: Anisur Rahman ChowdhuryRoll-117, Section A18th batchDepartment of MarketingUniversity of Dhaka | Prepared By: Submission Date: 31 March, 2016 Letter of Transmittal March 30, 2016 Prof. Dr. Masudur Rahman Professor Department of Marketing University of Dhaka Subject: A Research Paper on “How brand elements influence the consumers’ purchase intention of a brand: A study on Horlicks and GlaxoSmithKline” Dear Sir, This is an immense pleasure to submit my thesis paper on A Research Paper on “How brand elements influence the consumers’ purchase intention of a brand: A study on Horlicks and GlaxoSmithKline” as a partial fulfillment of BBA program. I hope this paper is informative and comprehensive as per your instruction. Here, I have worked with the consumer of “Horlicks” and tried to analyze their feedback to find out the impact of brand elements of “Horlicks & GlaxoSmithKline” on their purchase intention of Horlicks. Now, I am very grateful to you for your valuable supervision, precious time, effort and support......

Words: 12925 - Pages: 52

Premium Essay

Merck's Business Environment

...development and in turn, producing better products. After review of the income statements, Merck’s worldwide sales were $12 billion for the third quarter this year, an increase of 8 percent compared with the third quarter of 2010 (Newsroom, 2010). This revenue increase is mainly due to large sales of Gardasil, Singulair, and Isentress. When compared to other leaders in the industry, Merck’s sales for the quarter were $1 billion more than GlaxoSmithKline (GlaxoSmithKline plc, 2011), but almost $5 billion less than Pfizer (Pfizer Inc., 2011). Pfizer can attribute their large sales to the amount of assets that they hold, which was determined by the balance sheet. Also found on the balance sheet was the total liabilities and stock equity. One would think that since Pfizer produced more sales for the quarter, there price per share of stock would be higher than the competition, however this isn’t the case. In fact, Merck’s price per share is currently at $34.04 (Merck and Co. Inc., 2011) and GlaxoSmithKline’s is $44.41 (GlaxoSmithKline plc, 2011), despite producing less sales than Pfizer whose price per share is currently at $19.68 (Pfizer Inc., 2011). After reviewing the cash flow statement, the reason for the variety of stock prices deals with dividends paid. Pfizer faces significant revenue loss this November when the patent on the hugely popular cholesterol drug Lipitor expires. This is causing many shareholders to withdraw their stock from the company, decreasing......

Words: 2950 - Pages: 12

Premium Essay

Gsk Merger

...incentives, post merger value creation and industry position of the new entity e.g. merger between Glaxo Wellcome and SmithKline Beecham. 14 European Journal of Economics, Finance and Administrative Sciences - Issue 24 (2010) 1. Introduction GlaxoSmithKline is a UK based second largest pharmaceutical & healthcare company in the world. Headquartered in the UK and having listing on both New York stock exchange and London stock exchange. GSK is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market; GSK is the only pharmaceutical company researching both medicines and vaccines for the World Health Organization’s three priority diseases HIV/AIDS, tuberculosis and malaria. GSK employs over 100,000 people, has more than 80 manufacturing sites in 37 countries, and makes almost four billion packs of medicines and healthcare products each year. GSK spends £8 million (US$14 million) on research and development each day – that’s around £300,000 (US$562,000) every hour (GlaxoSmithKline, 2008). Moreover in 2007 the turnover decreased from 23.2 % in 2006 to 22.7 % a very challenging year for the company as GSK unexpectedly faced a severe decline in sales of Avandia, the second biggest product (GlaxoSmithKline, 2007). 2. Glaxo Wellcome Glaxo originates in New Zealand, where it was founded in 1873 by Joseph Nathan. Glaxo already knows the merger game as before Glaxo welcome was created in 1995 when Glaxo took over Wellcome for......

Words: 1304 - Pages: 6